本页面由Tiger Trade Technology Pte. Ltd.提供服务

Catabasis Pharmaceuticals, Inc.

8.54
0.0000
成交量:- -
成交额:- -
市值:1.10亿
市盈率:-0.16
高:8.54
开:8.54
低:8.54
收:8.54
52周最高:47.82
52周最低:6.31
股本:1,282.48万
流通股本:730.35万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-54.3943
每股收益(LYR):-12.1952
净资产收益率:-210.26%
总资产收益率:-20.32%
市净率:2.95
市盈率(LYR):-0.70

数据加载中...

2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/17

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/10

重要事件披露

8-K/A [Amend] - Current report
2021/06/02

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/19

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/16

重要事件披露

8-K - Current report
2021/04/14

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

重要事件披露

8-K - Current report